CATHERINE MCCANN-SHELTON: Open Payments
NPI 1861597056 · WILLIAMSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,201 in 94 payments from 16 companies in 2025. Trend: 2023 $1,336 · 2024 $2,088 · 2025 $2,201
Food & beverage: $2,201
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 23 | $584 |
| ABBVIE INC. | 22 | $503 |
| Janssen Biotech, Inc. | 14 | $293 |
| Ardelyx, Inc. | 6 | $152 |
| Ipsen Biopharmaceuticals, Inc | 4 | $127 |
| Lilly USA, LLC | 4 | $95 |
| PFIZER INC. | 4 | $87 |
| Phathom Pharmaceuticals, Inc. | 4 | $75 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $63 |
| Novo Nordisk Inc | 2 | $48 |
Products named: ENTYVIO, TREMFYA, RINVOQ, SKYRIZI, IBSRELA, IQIRVO, OMVOH, VOQUEZNA.
Industry payments across VA — which companies pay providers there.
